Literature DB >> 22684972

Comparison of microplate and macrodilution methods in time-kill study of new antimicrobial drugs.

Ying Zhou1, Zheng Hou, Chao Fang, Xiaoyan Xue, Fei Da, Yukun Wang, Hui Bai, Xiaoxing Luo.   

Abstract

In consideration of high production costs of new antimicrobial drugs, a more convenient and economical method for time-kill study is urgently required. In the present experiment, we attempted to demonstrate the feasibility of microplate method as an alternative measure of macrodilution method for time-kill study. Three conventional antibiotics (ciprofloxacin, ceftazidime, and levofloxacin) and two antimicrobial peptides [A-thanatin and K(4)-S4(1-16)a] were used to determine time-kill curves against Escherichia coli ATCC 25922 and Staphylococcus epidermidis ATCC 14990. Meanwhile, both methods were also performed with three antisense peptide nucleic acids (PNA3, PNA4, and PNA5) targeting ropD gene of Staphylococcus aureus ATCC 29213 and MRSA WHO-2. In order to study the correlation between the two methods, the growth inhibition rate of PNAs, antimicrobial peptides, and antibiotics for the tested strains were evaluated. A strong agreement between the results obtained from the two methods has been demonstrated. Although microplate method required longer incubation time for a significant result than macrodilution method, the former provides a more convenient, economical, and stable way to perform time-kill test for these agents. Thus, we concluded that microplate method was an available measure for time-kill study of new antimicrobial drugs.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22684972     DOI: 10.1007/s12223-012-0168-8

Source DB:  PubMed          Journal:  Folia Microbiol (Praha)        ISSN: 0015-5632            Impact factor:   2.099


  26 in total

Review 1.  Antibacterial peptides for therapeutic use: obstacles and realistic outlook.

Authors:  Alexandra K Marr; William J Gooderham; Robert Ew Hancock
Journal:  Curr Opin Pharmacol       Date:  2006-08-04       Impact factor: 5.547

2.  Antisense PNA accumulates in Escherichia coli and mediates a long post-antibiotic effect.

Authors:  Abbas Nikravesh; Rikard Dryselius; Omid R Faridani; Shan Goh; Majid Sadeghizadeh; Mehrdad Behmanesh; Anita Ganyu; Erik Jan Klok; Rula Zain; Liam Good
Journal:  Mol Ther       Date:  2007-05-29       Impact factor: 11.454

Review 3.  New antimicrobial agents for methicillin-resistant Staphylococcus aureus.

Authors:  Marin H Kollef
Journal:  Crit Care Resusc       Date:  2009-12       Impact factor: 2.159

Review 4.  Novel peptide therapeutics for treatment of infections.

Authors:  P C F Oyston; M A Fox; S J Richards; G C Clark
Journal:  J Med Microbiol       Date:  2009-06-15       Impact factor: 2.472

5.  Making sense of antisense in antibiotic drug discovery.

Authors:  Gerard D Wright
Journal:  Cell Host Microbe       Date:  2009-09-17       Impact factor: 21.023

6.  Antibacterial properties of dermaseptin S4 derivatives with in vivo activity.

Authors:  Shiri Navon-Venezia; Rina Feder; Leonid Gaidukov; Yehuda Carmeli; Amram Mor
Journal:  Antimicrob Agents Chemother       Date:  2002-03       Impact factor: 5.191

7.  Antisense phosphorodiamidate morpholino oligomer inhibits viability of Escherichia coli in pure culture and in mouse peritonitis.

Authors:  Bruce L Geller; Jesse Deere; Lucas Tilley; Patrick L Iversen
Journal:  J Antimicrob Chemother       Date:  2005-05-04       Impact factor: 5.790

8.  Restoration of antibiotic susceptibility in methicillin-resistant Staphylococcus aureus by targeting mecR1 with a phosphorothioate deoxyribozyme.

Authors:  Zheng Hou; Jing-Ru Meng; Chao Niu; Hai-Fang Wang; Jie Liu; Ben-Quan Hu; Min Jia; Xiao-Xing Luo
Journal:  Clin Exp Pharmacol Physiol       Date:  2007-11       Impact factor: 2.557

Review 9.  Antisense oligonucleotide drug design.

Authors:  N Schiavone; M Donnini; A Nicolin; S Capaccioli
Journal:  Curr Pharm Des       Date:  2004       Impact factor: 3.116

10.  Hitting bacteria at the heart of the central dogma: sequence-specific inhibition.

Authors:  Louise Carøe Vohlander Rasmussen; Hans Uffe Sperling-Petersen; Kim Kusk Mortensen
Journal:  Microb Cell Fact       Date:  2007-08-10       Impact factor: 5.328

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.